Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1264123

Ocular myasthenia gravis-like symptoms associated with erenumab: Case report


Marusic, Srecko; Andric, Jelena; Cigrovski Berkovic, Maja
Ocular myasthenia gravis-like symptoms associated with erenumab: Case report // International journal of clinical pharmacology and therapeutics, 61 (2023), 4; 178-180 doi:10.5414/CP204340 (međunarodna recenzija, prikaz, znanstveni)


CROSBI ID: 1264123 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Ocular myasthenia gravis-like symptoms associated with erenumab: Case report

Autori
Marusic, Srecko ; Andric, Jelena ; Cigrovski Berkovic, Maja

Izvornik
International journal of clinical pharmacology and therapeutics (0946-1965) 61 (2023), 4; 178-180

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, prikaz, znanstveni

Ključne riječi
erenumab ; migraine ; MG-like symptoms

Sažetak
Objective: We present a case of a patient who developed myasthenia gravis (MG)-like symptoms during erenumab treatment. Case report: The patient had a years-long history of chronic migraine with visual and sensory aura. Two months after the beginning of erenumab therapy, she reported intermittent bilateral weakness of the eyelids, with ptosis. The eyelid ptosis was severe enough to block the patient's vision. The symptoms would usually last between 5 and 10 minutes and resolve completely spontaneously, but they repeated on a daily basis. Antibodies against acetylcholine receptors and muscle-specific kinase were all negative, and other work-up excluded the usual etiology of ptosis. Since the cause of symptoms was not detected, we suspected they were induced by erenumab. The treatment was discontinued, and after 7 weeks from the last dose of erenumab, ocular symptoms resolved completely. In the presented case, other possible causes of MG-like symptoms were excluded by diagnostic tests and clinical course of the disease. The temporal relationship between the administration of erenumab and occurrence of ptosis, with regression of the symptoms after the drug discontinuation supports the hypothesis of causal relationship with erenumab. According to the Naranjo's Adverse Drug Reaction Probability Scale, erenumab-related MG-like symptoms were rated 'probable'. Reviewing the literature, we identified no similar case reports. Conclusion: Drug-induced MG-like symptoms might be life threatening. Therefore, clinicians should be aware of these adverse reactions during the use of erenumab.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Kineziološki fakultet, Zagreb,
Klinička bolnica "Dubrava"

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Marusic, Srecko; Andric, Jelena; Cigrovski Berkovic, Maja
Ocular myasthenia gravis-like symptoms associated with erenumab: Case report // International journal of clinical pharmacology and therapeutics, 61 (2023), 4; 178-180 doi:10.5414/CP204340 (međunarodna recenzija, prikaz, znanstveni)
Marusic, S., Andric, J. & Cigrovski Berkovic, M. (2023) Ocular myasthenia gravis-like symptoms associated with erenumab: Case report. International journal of clinical pharmacology and therapeutics, 61 (4), 178-180 doi:10.5414/CP204340.
@article{article, author = {Marusic, Srecko and Andric, Jelena and Cigrovski Berkovic, Maja}, year = {2023}, pages = {178-180}, DOI = {10.5414/CP204340}, keywords = {erenumab, migraine, MG-like symptoms}, journal = {International journal of clinical pharmacology and therapeutics}, doi = {10.5414/CP204340}, volume = {61}, number = {4}, issn = {0946-1965}, title = {Ocular myasthenia gravis-like symptoms associated with erenumab: Case report}, keyword = {erenumab, migraine, MG-like symptoms} }
@article{article, author = {Marusic, Srecko and Andric, Jelena and Cigrovski Berkovic, Maja}, year = {2023}, pages = {178-180}, DOI = {10.5414/CP204340}, keywords = {erenumab, migraine, MG-like symptoms}, journal = {International journal of clinical pharmacology and therapeutics}, doi = {10.5414/CP204340}, volume = {61}, number = {4}, issn = {0946-1965}, title = {Ocular myasthenia gravis-like symptoms associated with erenumab: Case report}, keyword = {erenumab, migraine, MG-like symptoms} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font